Fusion Antibodies PLC (LON:FAB)
11.50p
Spriggl Score: Weak— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Operating cash remains negative despite margin recovery; severe distress signals threaten total loss of capital.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Fusion Antibodies PLC
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offe…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £15.0M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Fusion Antibodies PLC and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free